Silk Road Medical Inc Quarterly Debt-to-equity in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Silk Road Medical Inc quarterly Debt-to-equity history and growth rate from Q3 2019 to Q2 2024.
  • Silk Road Medical Inc Debt-to-equity for the quarter ending June 30, 2024 was 72.9 %, a 7.49% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 72.9 -5.9 -7.49% Jun 30, 2024
Q1 2024 71.6 -23.2 -24.4% Mar 31, 2024
Q4 2023 69.9 -41.6 -37.3% Dec 31, 2023
Q3 2023 67.2 -69.4 -50.8% Sep 30, 2023
Q2 2023 78.8 -33.9 -30.1% Jun 30, 2023
Q1 2023 94.8 +3.59 +3.94% Mar 31, 2023
Q4 2022 112 +30.6 +37.8% Dec 31, 2022
Q3 2022 137 +62.8 +85.2% Sep 30, 2022
Q2 2022 113 +47.6 +73.1% Jun 30, 2022
Q1 2022 91.2 +33.1 +56.8% Mar 31, 2022
Q4 2021 81 +19 +30.7% Dec 31, 2021
Q3 2021 73.7 +7.66 +11.6% Sep 30, 2021
Q2 2021 65.1 -8.28 -11.3% Jun 30, 2021
Q1 2021 58.2 -25.1 -30.1% Mar 31, 2021
Q4 2020 62 -303 -83% Dec 31, 2020
Q3 2020 66.1 +282 Sep 30, 2020
Q2 2020 73.4 Jun 30, 2020
Q1 2020 83.2 Mar 31, 2020
Q4 2019 365 Dec 31, 2019
Q3 2019 -216 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.